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Abstract 
Using a scanning near-field optical microscope coupled to an infrared free electron laser 
(SNOM-IR-FEL) in low resolution transmission mode, we collected chemical data from whole 
cervical cells obtained from 5 pre-menopausal, non-pregnant women of reproductive age, 
and cytologically classified as normal or with different grades of cervical cell dyskaryosis. 
Imaging data are complemented by demography. All samples were collected before any 
treatment. Spectra were also collected using attenuated total reflection, Fourier-transform 
(ATR-FTIR) spectroscopy, to investigate the differences between the two techniques. Results 
of this pilot study suggests SNOM-IR-FEL may be able to distinguish cervical abnormalities 
based upon changes in the chemical profiles for each grade of dyskaryosis at designated 
wavelengths associated with DNA, Amide I/II, and lipids. The novel data sets are the first 
collected using SNOM-IR-FEL in transmission mode at the ALICE facility (UK), and obtained 
using whole cells as opposed to tissue sections, thus providing an “intact” chemical profile. 
These data sets are suited to complementing future work on image analysis, and/or applying 
the newly developed algorithm to other data sets collected using the SNOM-IR-FEL 
approach. 
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Background & Summary 
Conventional infrared (IR) spectroscopy techniques, such as attenuated total reflection, 
Fourier-transform infrared (ATR-FTIR) spectroscopy, are limited in spatial resolution by the 
effect of diffraction, defined as the interference of waves when they hit an obstacle or slit. 
This effect restricts the spatial resolution of FTIR to about half the wavelength of light or ~3 
µm to 30 µm1, with the resolution being a measure of how closely the lines of an image can 
be resolved (i.e., the number of independent pixels per value per unit length).  
Scanning near field optical microscopy (SNOM) belongs to a family of nanoscopic 
techniques that have shown potential in providing detailed information on cell topography 
and cytoplasmic structures. The technique has been used to determine the localisation of 
molecules within the cell membranes of prostate cancer cells2; to define the cell surface and 
internal structures of healthy and anomalous sperm3; and has demonstrated potential for 
single molecule imaging4. SNOM has a clear advantage over conventional IR microscopy in 
terms of spatial resolution because it is able to overcome the diffraction limit by the use of 
an apertured fibre optic scanning tip. However, SNOM requires relatively high photon 
intensities such as those provided by an IR free electron laser (IR-FEL). SNOM-IR-FEL enables 
the simultaneous collection of topography and optical features at scales not normally 
achieved with conventional IR techniques, to produce high quality, chemically-rich images at 
designated wavelengths with a spatial resolution of ~0.2 µm5,6.  
In 2009, an IR oscillator FEL was installed into ALICE (Accelerators and Lasers in Combined 
Experiments), a specific accelerator test facility using the superconducting Energy Recovery 
Linac (ERL) at Daresbury Laboratory (Warrington, UK)7. Set–up, functionality and diagnostics 
of the ALICE IR-FEL laser have been extensively documented together with the results of the 
first lasing of ALICE being achieved at a wavelength of 8 µm7,8,9. Further developments have 
included the FEL beam being carried to a diagnostics room, the optimization of the IR-FEL at 
different wavelengths and the coupling to a SNOM.  
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In 2013, SNOM-IR-FEL was used to investigate the chemical differences between non-
dysplastic Barrett’s oesophagus and Barret’s associated oesophageal adenocarcinoma5. Of 
note, is that researchers where blinded to the samples and were asked to identify them post 
experiment. The SNOM-IR-FEL images showed a large contrast in DNA and 
proteins/glycoproteins between the samples. Since elevated levels of DNA and proteins are    
associated with the development of cancer10, the experimenters were able to correctly 
identify cancer tissue from benign tissue5.   
The optical chemical imaging data presented here were acquired in the context of a pilot 
study conducted in 2015, to determine the feasibility and utility of using SNOM-IR-FEL in 
transmission mode in the detection of the biophysical properties of cervical cell 
abnormalities. During our experiment, the IR-FEL at ALICE was tuneable over the range of 5.5 
µm to 8.8 µm (~1818 cm-1 to ~1136 cm-1), which includes a number of biologically important 
biomarkers11 at designated wavenumbers or wavelengths within the ‘fingerprint’ region 
(1800-900 cm-1).  Previous work has shown that ATR-FTIR spectroscopy is able to diagnose 
underlying cervical disease and segregate grades of cervical dyskaryosis more precisely than 
conventional cytology based upon changes within the ‘fingerprint’ region12,13. We selected 
four wavenumbers/wavelengths from this region to explore with SNOM-IR-FEL (Table 1).  
Spectra were also collected using traditional ATR-FTIR biospectroscopy to investigate the 
differences between methods. The results of this pilot study have been published and 
evidence the promise of the SNOM-IR-FEL technique14.  
The data sets presented here are novel for two reasons. Firstly, they are the first data set 
collected using SNOM-IR-FEL in transmission mode at the ALICE facility. Secondly, the data 
were collected by imaging whole cells as opposed to tissue sections, thus providing an 
‘intact’ chemical profile. These data sets are suited to complementing future work on image 
analysis, and/or applying the newly developed algorithm to other data sets collected using 
the SNOM-IR-FEL approach.  
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Methods 
The study was approved by the National Research Ethics Service Committee London – 
Fulham (Approval number 13/LO/0126), and conducted according to the principles of the 
Declaration of Helsinki and all other applicable national or local laws and regulations. All 
patients gave written informed consent before any protocol-specific procedure was 
performed.  
Patient recruitment  
Patients (5 pre-menopausal, non-pregnant females, aged 25 to 45 years of age) were 
selected from a larger cohort of patients taking part in a larger study who were scheduled, if 
necessary, to undergo local cervical treatment at Imperial College NHS Healthcare Trust. 
Patients selected for this study were based on their cytology and histology typing (worse 
grade) to match a diagnosis of ‘normal’, squamous lesions (low-grade dyskaryosis and high-
grade dyskaryosis), pre-invasive mixed lesions involving both squamous and glandular cells 
(squamous defined as cervical intraepithelial neoplasia 2 [CIN2]; glandular defined as high-
grade cervical glandular intraepithelial neoplasia [HGCGIN]), or developed glandular lesions 
(adenocarcinoma). All samples were collected prior to treatment. Patients were anonymised 
and assigned a unique identifier.  
We collected patient characteristics that included ethnicity, parity, smoking habits, 
antibiotic use within the last 2 weeks, phase in their cycle and use of contraception. The type 
of contraception and the time of their cycle (follicular or luteal) were documented. Medical 
and gynaecological history was collected for each patient including time since last sexual 
intercourse. For each patient, we collected data on the cytology, HPV DNA test and typing 
and histology, if available. Ethnicity was self-reported as Caucasian, Asian or Black. Women 
who were HIV or hepatitis B/C positive, women with autoimmune disorders, and women 
that received pessaries within 14 days of sampling were excluded. Women with a previous 
history of cervical treatment were also excluded. 
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Cervical cells collection  
A sterile, disposable speculum was inserted, without lubricant, and a cervical sample of 
ThinPrep, liquid-based cytology (LBC) was taken from the cervix (ThinPrep, HOLOGIC Inc., 
Bedford, USA). This was analysed for cytological diagnosis and HPV DNA test and typing. HPV 
DNA test and 16/18 genotyping was carried out according to manufacturer’s guidelines using 
the Abbott RealTime High Risk (HR) HPV assay on Abbott M2000 platform; a clinically 
validated in vitro polymerase chain reaction (PCR) assay with identification of HPV-16, -18 
and 12 other HR HPV subtypes (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68)15. From the 
remaining methanol-based fluid, 1 ml was stored at 4° centigrade at the Centre for 
Biophotonics, Lancaster University, England, until preparation for SNOM-IR-FEL and ATR-FTIR 
analysis.  
Cytology and histology typing  
In the UK, the NHS Cervical Screening Programme (NHSCSP) adopted the revised British 
Society Clinical Cytology (BSCC) terminology into their new guidelines for the classification of 
cervical cytology in 201316. Outside of the UK, the Bethesda system is widely used17. A 
summary of both classification systems are presented in Supplementary Tables 1 and 2 for 
squamous and glandular lesions, respectively. An overview of how cervical cytology and 
histology are determined is provided, as are images for cervical cytology and histology for 
normal, low-grade dyskaryosis, high-grade dyskaryosis and squamous and glandular cervical 
cancers18-22. 
Slide preparation  
Each sample was agitated to disperse the cell pellet, and then a 500 µl aliquot was collected 
from the 1 ml sample into a clean micro tube. The 500 µl aliquots were centrifuged at 2000 
rpm for 5 minutes and the ThinPrep supernatant was aspirated from above the pellet to 
remove its spectral signature (i.e., the methanol fixative). Each sample was re-suspended in 
500 µl of distilled H2O, agitated and centrifuged again. The supernatant was removed again 
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and the wash step was repeated once more. For ATR-FTIR analysis, the final pellet was 
immersed in 100 µl of distilled H2O, agitated and dispensed onto IR-reflective glass slides 
(Low-E; Kevley Technologies Inc., Chesterland, OH, USA) in a uniform spread of whole cells 
and allowed to bench dry for a minimum of 24 hours. Samples were then stored in a 
desiccator for a minimum of 48 hours to remove any residual water before spectral analysis. 
For SNOM-IR-FEL analysis, the remaining 500 µl aliquot was washed as described above. If 
the final pellet was small, it was suspended in 500 µl of distilled H2O, and larger pellets in 
1000 µl of distilled H2O. Each suspension was then agitated to disperse the pellet, and 5-6 
drops added to a cytofunnel held in a cytoclip that had been pre-loaded with a BaF2 slide; 
(Crystan Ltd, Dorset, UK). Samples were spun at 3000 rpm for 5 minutes in a Cytospin™ 4 
Cytocentrifuge (Thermo Fisher Scientific Inc., MA, USA) to disperse the cells in a single layer 
onto the slide. Slides were then housed in slide cartridges and kept in a desiccator until 
required.   
SNOM and IR-FEL experimental set-up 
The experiments were performed on the IR-FEL beamline at the ALICE energy recovery linear 
accelerator at Daresbury Laboratory7,8,9. The wavelength of light from the FEL was selected 
by changing the undulator gap and, at the present accelerator settings, could be varied 
continuously from about 5.5 µm to 8.8 µm (~1818 cm-1 to ~1136 cm-1), a range which covers 
a number of biologically important absorption bands11. The IR-FEL operates at a macro-pulse 
width of ~10 µs and a repetition rate of 10 Hz, which limits, and determines, the rate of data 
collection. The IR light from the FEL was transported to the experimental area via an 
evacuated beamline and exited the beamline through a KBr window. The intensity of the FEL 
radiation was attenuated using a set of polarisers and focussed onto the sample. A CaF2 
beam-splitter enabled the FEL radiation to be split so that approximately 80% went to the 
SNOM and 20% was used as a reference signal. The reference signal was monitored with a 
single-element pyro detector (Gentec-EO UM9B-BL-D0, Banbury, Oxon UK). 
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The general principal of operation for the SNOM used in these experiments has been 
previously described6. In brief, the scanning tip is a specially prepared infrared-transmitting 
Chalcogenide glass fibre, where one end is usually etched to a sharp tip. Gold is then 
evaporated onto the tip so that it covers all but the very end, forming an aperture of 0.1-1 
µm in diameter through which the light is coupled and collected. The sample is rastered 
under the tip, using an x-y Piezo-scanner, whilst keeping the tip-to-sample shear-force 
constant through an electro-mechanic feedback. A single IR-FEL macro-pulse is used for each 
pixel of the images. The standard mode of operation for IR-SNOM is reflection, where the 
light approaches the sample at a grazing incidence angle of approximately 15° and the 
reflected light is collected by the fibre, transmitted through the fibre and detected using a 
liquid nitrogen cooled mercury-cadmium-telluride (MCT) detector.  
For the measurements reported here, the data were acquired in transmission mode, 
where the sample was illuminated through the slide, and the light that was transmitted 
through the sample was collected by the fibre. The fibre was cleaved, rather than etched, so 
the entire 6-µm diameter fibre core was used to collect the infrared light signal; this enabled 
a direct comparison with standard IR techniques such as ATR-FTIR spectroscopy. The SNOM 
was incorporated into an inverted optical microscope, which was used to locate specific cells 
of interest on the sample and to position them within the SNOM scan area.  
A BaF2 slide containing the cells was mounted onto the SNOM and scans acquired at fixed 
wavelengths of 5.71 µm/~1750 cm-1 (lipids), 6.06 µm/~1650 cm-1 (amide I), 6.46 µm/~1550 
cm-1 (amide II) and 8.16 µm/~1225 cm-1 (DNA-asymmetric phosphate) for each set of cells. 
Each SNOM data set was collected at a one IR-FEL wavelength. The tip height (topography, or 
TOPO), raw transmission intensity (SNOM) and an IR-FEL intensity reference signal (ZERO) 
were simultaneously collected for each pixel, yielding three images to comprise one SNOM 
data set. During data acquisition, two independent data sets were sequentially collected. For 
each row of the image, the “forward” set was collected whilst the sample was moving in one 
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direction and then the “backward” set whilst the sample was moving in the opposite 
direction; then the same was repeated for each row of the image. 
ATR-FTIR spectroscopy  
Spectra were acquired using a Tensor 27 FTIR spectrometer with a Helios ATR attachment 
(Bruker Optik GmbH). Each spectrum comprised 32 scans at 8 cm-1 wavenumber spacing 
with 2 x interferogram zero-filling. Before the spectra were taken, the crystal was cleaned 
with distilled H2O and inspected by video camera to be free of any contaminants. A 
background spectrum was acquired before the sample slide was mounted and the stage 
moved to bring the cervical cells in contact with the diamond. Spectra were collected from 
ten random sites on the slide. Spectra were converted to absorbance by Bruker OPUS 
software (Bruker Inc., Billerica, MA, USA). 
Pre-processing of SNOM-IR-FEL image data sets 
The raw forward and backward SNOM transmission image data sets were loaded into the 
freely available software Gwyddion 2.40, available at http://gwyddion.net/, and converted 
into text files ready for importing into MATLAB. No other pre-processing was performed 
other than file conversion; the images were not corrected for IR-FEL intensity variations. A 
second set of raw data files were converted into jpgs following image enhancement using 
Gwyddion; these files were used for the images of the data shown in this work.  
SNOM-IR-FEL image enhancement   
The images presented in Fig. 1 were processed for presentation using Gwyddion 2.40.  
Median height line correction in the horizontal (fast scan) axis was applied, followed by the 
removal of high frequency noise using a two-dimensional Fourier transform.   
Computational analysis:  
SNOM-IR-FEL transmission image data sets 
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The raw SNOM transmission image data sets were processed using MATLAB software 2014a 
(Mathworks Inc., Natick, MA, USA) and PLS Toolbox version 7.9.3 (Eigenvector Research, Inc., 
WA, USA). For each cell studied, a set of four raw SNOM transmission image data files, 
corresponding to the four wavelengths used (e.g. each biomarker response), were imported 
into MATLAB as four matrixes with size of 150 x 150 (Fig. 1). To obtain a spectrum-like signal 
profile from the biomarker response, the biomarker data matrix was converted into a vector 
by the mean calculation of the matrix in the column-mode direction (Equation. 1), where,    
is an element of the row-vector   {1 x 150}, corresponding to the spectrum-like signal; m is 
the size of the image on column-mode direction; and     is an element of the biomarker 
matrix  . 
   
 
 
    
 
   
 
Equation. 1 
Thereafter, the spectrum-like signal was normalized by mean-centring and absolute value. 
The bar charts were made with the area of the spectrum-like signal integrated into an 
interval of spatial distribution according to the cell content position (Fig. 1).  
Principal component analysis (PCA) was performed with the whole spectrum-like signal 
using only mean-centring and absolute value as pre-processing. A summary of the 
computational steps in processing the data is given in Fig. 2. PCA is an unsupervised 
technique commonly used as the first step in analysing large, multivariate data sets. 
Unsupervised techniques require no information from the user but rely instead on an 
internal criterion to guide learning. In unsupervised learning, the system forms clusters 
(groupings, regions of data space). In general terms, PCA reduces the dimensionality of large 
data sets and using mathematical projection, the original data set which may have involved 
many variables, can often be interpreted in just a few variables (i.e., the principal 
components; PCs). This reduced dimensional data set will allow the user to spot trends, 
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patterns and outliers in the data, far more easily than would have been possible without 
performing the PCA. When applied to spectra, PCA identifies common sources of variance 
across spectra and collates them into a small number of dimensions. PCA is often not enough 
to segregate out data classes or clusters sufficiently. By applying a supervised technique such 
as Linear Discriminant Analysis (LDA) to the PCA output, it promotes inter-class variation to 
be identified whilst preventing over-fitting of the data. 
PCA was executed using the average signal of each biomarker (triplicate) for five samples, 
one for each type of cell morphology: normal, low-grade dyskaryosis, high-grade dyskaryosis, 
CIN2, HGCGIN and adenocarcinoma Stage 1B1. Additionally, the area for each biomarker for 
each cell type was determined, as was the percentage area variation from ‘normal’ for each 
biomarker for each cell type.  
ATR-FTIR spectra 
The ATR-FTIR data were analysed using multivariate techniques of PCA for preliminary data 
reduction, and the output was processed using LDA and a variable selection technique 
employing Successive Projections Algorithm (SPA)23, in conjunction with LDA for selecting an 
appropriate subset of wavenumbers for classification purposes. SPA is a variable selection 
technique specifically designed to improve the conditioning of multiple linear regression by 
minimizing collinearity effects in the calibration data set and can result in models with good 
prediction ability24. 
The classic Kennard–Stone (KS) uniform sampling algorithm25 was adopted to divide the 
available samples into training (70%), validation (15%) and prediction sets (15%) for 
construction and validation of the PCA-LDA and SPA-LDA models. The training set was used 
to obtain model parameters (including variable selection for LDA), and the validation set was 
employed to choose the best number of the PCs for PCA model and to guide the variable 
selection. The optimum number of variables for SPA–LDA was used to select variables 
employing the G function as cost function25. 
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Code availability 
Morais, C. L. M. & Lima, K. M. G. Source code for: An imaging dataset of cervical cells using 
scanning near-field optical microscopy coupled to an infrared free electron laser. Figshare: 
https://dx.doi.org/10.6084/m9.figshare.3479003.v1 (2016).  
 
Data Records 
The data are available through at the following link under the collection name 
“Data_Science_SNOM_Sets” (Data citation 1). 
 https://figshare.com/articles/Data_Science_SNOM_Sets_zip/3971883 
Demographic data 
These are considered as metadata, informing the imaging data. Fully documented patient 
characteristics are available for 4 out of the 5 patients; limited demography is available for 
the patient typed with high-grade dyskaryosis. There is one metadata.pdf summarizing the 
data and one metadata.doc file. Both of these files can be located in the folder named 
‘metadata.’ 
SNOM-IR-FEL imaging data  
Raw data  
The raw SNOM data sets are available as AFM files and are located in the folder labelled 
‘Collated_FB_SNOM_Raw,’ with sub-folders containing data specific to individual patients 
and labelled as ‘Normal,’ ‘Low_Grade_Dyskaryosis,’ ‘High_Grade_Dyskaryosis,’ 
‘Mixed_Lesion_CIN2_HGCGIN,’ and ‘Adenocarcinoma_Stage1B1.’ Each file is numbered to 
include the patient ID together with labelling for either the forward or backward image data. 
For example, the data file ‘0195-C21211-BSNOM.AFM’, has the prefix of 0195 which refers to 
the sequential numbering in which the images were collected. C212 refers to the patient ID 
followed by the area ‘II’ (one of one). The direction of the scan is indicated with the next 
letter: F for forward and B for backward. This is then followed by four letters indicating the 
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type of data. SNOM is the raw SNOM transmission data, TOPO is the raw topography (e.g., 
0195-C21211-FTOPO.AFM) and ZERO is the raw IR-FEL intensity reference signal data (e.g., 
0195-C21211-FZERO.AFM). The data analysis described in this paper uses only the SNOM 
image data files; the TOPO and ZERO files are included for completion and would, in general, 
be used for other types of analysis. 
The data contained in the SNOM and ZERO files are separately proportional to the 
intensity of the detected light within a given data set. The absolute values are attenuated by 
the polarisers, the detectors, the box car integrators and by the Analogue-to-Digital 
converters; the polarisers and box car integrator sensitivity are adjusted separately for 
SNOM and ZERO for each data set (a set of data with the same sequential number). 
Therefore, each signal has a different offset and scaling factor. Most of the data contained in 
the header files was input manually; the exceptions are the first 3 lines and the last 5 lines. 
The provision of header files is under development and these files were not meant for 
publication at this early stage. Whilst the operators endeavoured to make sure the data was 
correct, it is inevitable that sometimes parameters were not changed when they should have 
been. As the work reported in this paper did not use most of the information in the header 
files, no attempt was made to check to accuracy of the data therein. 
Converted SNOM imaging data to txt files  
Raw SNOM transmission data from each patient is also available as a txt file (converted from 
the raw AFM files) using Gwyddion 2.40. The txt file, can be opened in many applications 
including MATLAB, to reveal a matrix of values that are proportional to the intensity of the 
FEL light being detected for a given image; lower voltages correspond to less intensity of the 
FEL light being detected at that point in the sample. Each file is numbered as above, 
replacing the ‘AFM’ extension with a txt extension. These data are stored in a folder labelled 
‘Collated_FB_SNOM_TXT,’ and individual patient data is collated into sub-folders labelled as 
described above (Table 1). To complement the above, some of the experimental parameters 
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for each SNOM image are collated together into one convenient Excel spreadsheet called 
‘SNOM_Data_Spreadsheet,’ which details where possible, scan steps, scan size and FEL 
power amongst others.  
ATR-FTIR spectroscopy data  
Data for each patient is available as an OPUS binary format file and collated into patient-
specific sub-folders as described above (Table 2). Each file extension contains the date on 
which the data were collected. These data can be readily accessed and worked with via 
IRootlab26 (available at http://trevisanj.github.io/irootlab/.) 
 
Technical Validation 
 
Samples 
We included a sample collected from a patient with normal cervical cytology and infected 
with HPV ‘other type’ (i.e., not high-risk oncogenic types 16 or 18). As such, this provided a 
reference sample to compare the other samples with various grade of lesions, some of which 
were infected with high-risk oncogenic types.   
Cytology and histology typing  
Images for cervical cytology and histology of normal, squamous and glandular lesions are 
provided18-22.  
Atomic force microscopy (AFM) imaging of cells 
To evidence that whole cervical cells had been used to collect the SNOM-IR-FEL data, atomic 
force microscopy (AFM) was performed on the adenocarcinoma stage 1B1 sample, using a 
Bruker Innova AFM in contact mode using silicon nitride probes of nominal spring constant 
0.07 N/m. Topography and deflection (error signal) channels were recorded simultaneously. 
The contact force of the AFM tip on the cells was minimised to optimise image quality. These 
AFM images have been previously reported14. 
SNOM-IR-FEL 
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No optical structures were observed in the reference signal. SNOM data sets were collected 
from the normal sample as a reference point in order to distinguish optical data distribution 
for the different types of cervical lesions.  
Computational analysis 
The SNOM-IR-FEL reduced data were evaluated according to the following statistical 
parameters: variance, standard error, sample bias and mean squared error (MSE). The 
statistical results for the forward and backward mode are shown in Tables 3 and 4, 
respectively. The variance, standard error, bias and MSE were very small showing almost no 
variation between the various cells of the same type that were imaged. The data is almost 
unbiased to its mean, which shows the reproducibility of the reduced data between 
replicates of cells collected in different positions on the sample slide. The SNOM images used 
for analysis have been previously reported14. 
These same statistical parameters for whole ATR-FTIR spectra are provided in Table 5. As 
can be seen, the variance, standard error, bias and MSE for ATR-FTIR data were also very 
small, showing almost no variation between replicates of spectra and unbiased trend. 
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Figure Legends 
Figure 1. Transmission IR-SNOM images (400 µm x 400 µm) of the same cell sampled from pre-
invasive lesion (CIN2, HGCGIN) at the different biomarker wavelengths: (a) Amide I - 6.06 µm (~1650 
cm
-1
), the horizontal line in (a) is shown in cross section in (b), (c) Amide II - 6.46 µm (~1550 cm
-1
), (d) 
DNA - 8.1µm (~1225 cm
-1
) and (E) Lipids - 5.71 µm (1750 cm
-1
).  The colour scale bar arrow indicates 
decreasing biomarker signal transmission, meaning increasing biomarker absorption. The shaded 
region in (b) corresponds to the interval selected for area calculation according to the cell content. 
CIN2, HGCGIN: Cervical intra-epithelial neoplasia, high-grade cervical glandular intraepithelial 
neoplasia.  
Figure 2. The computational steps taken in processing the data. 
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Table 
Subjects 
(cytology & 
histology type) 
(Subject ID) 
Number 
of cells 
imaged 
by 
SNOM-IR-
FEL  
Wavenumber  
(cm
-1
) 
(wavelength, 
µm) 
Tentative 
assignment of 
biomarker  
Data set folders:  
‘Collated_FB_SNOM-Raw’ & 
‘Collated_FB_SNOM_TXT’ 
Normal  
(MK212) 
16 ~1225 (8.16) 
 
 
~1550 (6.46) 
 
 
 
~1650 (6.46) 
 
 
 
~1750 (5.71) 
 
DNA – asymmetric 
phosphate 
 
Amide II of proteins 
predominantly in β 
sheet conformation 
 
Amide I of proteins 
predominantly in α 
helix conformation 
 
Lipids 
Sub-folder: Normal 
Low-grade  
dyskaryosis 
(MK177) 
6 As above As above Low_Grade_Dyskaryosis 
High-grade 
dyskaryosis 
(MK126A) 
2 As above As above High_Grade_Dyskaryosis 
CIN2, HGCGIN 
(MK162) 
5 As above As above  Mixed_Lesion_CIN2_HGCGIN 
Adenocarcinoma 
Stage 1B1 
(MK238) 
5 As above  As above  Adenocarcinoma_Stage1B1 
CIN2, HGCGIN: Cervical intraepithelial neoplasia 2, high-grade cervical glandular intraepithelial 
neoplasia: SNOM-IR-FEL: Scanning near-field optical microscopy coupled with an electron free laser.  
Table 1. Patients’ information with cytology and histology typing, number of cells imaged at each 
wavenumber (cm
-1
)/wavelength (µm) by SNOM-IR-FEL and associated data folders containing either 
‘raw’ forward and back SNOM images, topography and a FEL intensity reference signal; and converted 
AFM files into txt files. Additional demographic data is available within the data set (metadata.pdf).  
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Subjects (cytology & histology 
type); (Subject ID) 
Number of scans collected by 
ATR-FTIR spectroscopy   
Data set folder: ATR_FTIR 
Normal (MK212) 10 Sub-folder: Normal  
 
Low-grade  
dyskaryosis (MK177) 
10 Sub-folder: Low_Grade_Dyskaryosis  
High-grade 
dyskaryosis (MK126A) 
10 Sub-folder: 
High_Grade_Dyskaryosis  
 
CIN2, HGCGIN (MK162) 10 Sub-folder: 
Mixed_Lesion_CIN2_HGCGIN  
 
Adenocarcinoma Stage 1B1 
(MK238) 
10 Sub-folder: 
Adenocarcinoma_Stage1B1  
 
ATR-FTIR: Attenuated total reflection, Fourier-transform spectroscopy; CIN2, HGCGIN: Cervical 
intraepithelial neoplasia 2, high-grade cervical glandular intraepithelial neoplasia.  
Table 2. Patients’ information with cytology and histology typing, and the number and location of 
scans collected by ATR-FTIR spectroscopy.        
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Cell type  
(Subject ID) 
Biomarker  Variance Standard error Bias MSE 
Normal (MK212) Amide I
a
 7.77x10
-21
 3.60x10
-11
 -1.29x10
-26
 1.30x10
-21
 
 Amide II
b
 2.31x10
-21
 1.60x10
-11
 -5.74x10
-27
 2.56x10
-22
 
 DNA
c
 1.15x10
-21
 1.20x10
-11
 -1.78x10
-26
 1.44x10
-22
 
 Lipids
d
 6.83x10
-22
 1.07x10
-11
 1.94x10
-26
 1.14x10
-22
 
Low-grade 
dyskaryosis 
(MK177) 
Amide I
a
 4.44x10
-22
 1.05x10
-11
 0.00 1.10x10
-22
 
 Amide II
b
 3.17x10
-22
 1.03x10
-11
 8.62x10
-27
 1.06x10
-22
 
 DNA
c
 1.74x10
-22
 6.60x10
-12
 0.00 4.36x10
-23
 
 Lipids
d
 1.14x10
-21
 1.69x10
-11
 3.23x10
-27
 2.86x10
-22
 
High-grade 
dyskaryosis  
(MK126) 
Amide I
a
 2.14x10
-23
 3.27x10
-12
 1.29x10
-26
 1.07x10
-23
 
 Amide II
b
 3.25x10
-23
 4.03x10
-12
 -1.29x10
-26
 1.62x10
-23
 
 DNA
c
 3.31x10
-21
 2.35x10
-11
 -6.46x10
-27
 5.52x10
-22
 
 Lipids
d
 2.13x10
-21
 3.26x10
-11
 1.29x10
-26
 1.06x10
-21
 
CIN2, HGCGIN 
(MK162) 
Amide I
a
 7.05x10
-22
 1.88x10
-11
 1.29x10
-26
 3.53x10
-22
 
 Amide II
b
 1.34x10
-24
 1.16x10
-12
 0.00 1.35x10
-24
 
 DNA
c
 3.45x10
-22
 9.29x10
-12
 -1.29x10
-26
 8.63x10
-23
 
 Lipids
d
 9.99x10
-22
 2.24x10
-11
 -1.29x10
-26
 5.02x10
-22
 
Adenocarcinoma 
Stage 1B1 
(MK238) 
Amide I
a
 1.28x10
-21
 1.79x10
-11
 -3.23x10
-27
 3.20x10
-22
 
 Amide II
b
 1.94x10
-21
 2.20x10
-11
 9.69x10
-27
 4.84x10
-22
 
 DNA
c
 3.97x10
-20
 7.53x10
-11
 -4.06x10
-26
 5.67x10
-21
 
 Lipids
d
 6.68x10
-21
 4.72x10
-11
 -4.31x10
-27
 2.23x10
-21
 
a
Amide I: 1650cm
-1
; 
b
Amide II: 1550 cm
-1
; 
c
DNA: 1225 cm
-1
; 
d
Lipids: 1750 cm
-1
. 
CIN2, HGCGIN: Cervical intraepithelial neoplasia 2, high-grade cervical glandular intraepithelial 
neoplasia.  
 
Table 3. Average variance, standard error, sample bias and mean squared error (MSE) for SNOM 
transmission image data in forward mode. All parameters are represented as relative absorbance. 
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Cell type 
(Subject ID) 
Biomarker  Variance Standard error Bias MSE 
Normal 
(MK212) 
Amide I
a
 7.36x10
-21
 3.50x10
-11
 8.62x10
-27
 1.22x10
-21
 
 Amide II
b
 1.75x10
-21
 1.58x10
-11
 1.29x10
-26
 2.50x10
-22
 
 DNA
c
 1.19x10
-21
 1.22x10
-11
 3.23x10
-27
 1.49x10
-22
 
 Lipids
d
 9.95x10
-22
 1.29x10
-11
 4.31x10
-27
 1.66x10
-22
 
Low-grade 
dyskaryosis 
(MK177) 
Amide I
a
 6.86x10
-22
 1.51x10
-11
 0.00 2.28x10
-22
 
 Amide II
b
 3.10x10
-22
 1.02x10
-11
 0.00 1.04x10
-22
 
 DNA
c
 2.36x10
-22
 7.68x10
-12
 -6.46x10
-27
 5.90x10
-23
 
 Lipids
d
 1.48x10
-21
 2.22x10
-11
 8.62x10
-27
 4.93x10
-22
 
High-grade 
dyskaryosis 
(MK126) 
Amide I
a
 2.03x10
-23
 3.19x10
-12
 1.29x10
-26
 1.02x10
-23
 
 Amide II
b
 3.04x10
-23
 3.90x10
-12
 1.30x10
-26
 1.52x10
-23
 
 DNA
c
 1.97x10
-21
 1.81x10
-11
 -2.37x10
-26
 3.28x10
-22
 
 Lipids
d
 2.04x10
-21
 3.19x10
-11
 -6.46x10
-27
 1.02x10
-21
 
CIN2, HGCGIN 
(MK162) 
Amide I
a
 3.41x10
-21
 3.37x10
-11
 -4.31x10
-27
 1.14x10
-21
 
 Amide II
b
 1.49x10
-24
 1.22x10
-12
 0.00 1.49x10
-24
 
 DNA
c
 2.08x10
-22
 8.32x10
-12
 -8.62x10
-27
 6.92x10
-23
 
 Lipids
d
 9.92x10
-22
 2.23x10
-11
 6.46x10
-27
 4.97x10
-22
 
Adenocarcinoma 
Stage 1B1 (MK238) 
Amide I
a
 1.28x10
-21
 2.07x10
-11
 8.62x10
-27
 4.28x10
-22
 
 Amide II
b
 1.91x10
-21
 2.19x10
-11
 -1.29x10
-26
 4.80x10
-22
 
 DNA
c
 3.99x10
-20
 7.54x10
-11
 1.48x10
-26
 5.69x10
-22
 
 Lipids
d
 6.85x10
-21
 4.78x10
-11
 0.00 2.28x10
-21
 
a
Amide I: 1650 cm
-1
; 
b
Amide II: 1550 cm
-1
; 
c
DNA: 1225 cm
-1
; 
d
Lipids: 1750 cm
-1
. 
CIN2, HGCGIN: Cervical intraepithelial neoplasia 2, high-grade cervical glandular intraepithelial 
neoplasia.  
Table 4. Average variance, standard error, sample bias and mean squared error (MSE) for SNOM 
transmission image data in backward mode. All parameters are represented as relative absorbance. 
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Cell type 
(Subject ID) 
Variance Standard error Bias MSE 
Normal (MK212) 9.88x10
-11 
– 
1.80x10
-06
 
3.14x10
-06 
– 
4.24x10
-04
 
-1.42x10
-08 
– 
1.11x10
-08
 
9.88x10
-12 
– 
1.80x10
-07
 
Low-grade dyskaryosis (MK177) 1.95x10
-10 
– 
7.62x10
-07
 
4.42x10
-06
 – 
2.76x10
-04
 
-8.94x10
-09 
– 
1.19x10
-08
 
1.95x10
-11 
– 
7.62x10
-08
 
High-grade dyskaryosis (MK126) 5.55x10
-10
 – 
1.67x10
-06
 
7.45x10
-06
 – 
4.08x10
-04
 
-1.27x10
-08 
– 
1.34x10
-08
 
5.55x10
-11 
– 
1.67x10
-07
 
CIN2, HGCGIN (MK162) 2.92x10
-10
 – 
7.02x10
-07
 
5.40x10
-06
 – 
2.65x10
-04
 
-1.04x10
-08 
– 
1.04x10
-08
 
2.92x10
-11 
– 
7.02x10
-08
 
Adenocarcinoma Stage 1B1 (MK238) 2.53x10
-10
 – 
7.35x10
-07
 
5.03x10
-06
 – 
2.71x10
-04
 
-1.27x10
-08 
– 
1.64x10
-08
 
2.53x10
-11 
– 
7.34x10
-08
 
CIN2, HGCGIN: Cervical intraepithelial neoplasia 2, high-grade cervical glandular intraepithelial 
neoplasia.  
Table 5. Variance, standard error, bias and average mean squared error (   ) for replicates of ATR-
FTIR spectra. All parameters are represented as absorbance units. 
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